Epigenetic Therapy Leaps Ahead with Specific Targeting of EZH2

被引：25

作者：

Melnick, Ari ^{[1
,2
]}

机构：

[1] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA

[2] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA

来源：

CANCER CELL | 2012年 / 22卷 / 05期

关键词：

B-CELL LYMPHOMAS; METHYLATION; H3K27;

D O I：

10.1016/j.ccr.2012.10.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Polycomb epigenetic silencing protein EZH2 is affected by gain-of-function somatic mutations in B cell lymphomas. Two recent reports describe the development of highly selective EZH2 inhibitors and reveal mutant EZH2 as playing an essential role in maintaining lymphoma proliferation. EZH2 inhibitors are thus a promising new targeted therapy for lymphoma.

引用

页码：569 / 570

页数：2

共 50 条

[1] Targeting EZH2 in cancer therapy
Yamagishi, Makoto
Uchimaru, Kaoru
CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
[2] Targeting EZH2 as cancer therapy Comment
Hanaki, Shunsuke
Shimada, Midori
JOURNAL OF BIOCHEMISTRY, 2021, 170 (01) : 1 - 4
[3] Targeting EZH2 for Cancer Therapy: Progress and Perspective
Li, Chi Han
Chen, Yangchao
CURRENT PROTEIN & PEPTIDE SCIENCE, 2015, 16 (06) : 559 - 570
[4] Review: Targeting EZH2 in neuroblastoma
Gao, Jinhui
Fosbrook, Claire
Gibson, Jane
Underwood, Timothy J.
Gray, Juliet C.
Walters, Zoe S.
CANCER TREATMENT REVIEWS, 2023, 119
[5] Targeting EZH2 and PRC2 dependence as novel anticancer therapy
Xu, Bowen
Konze, Kyle D.
Jin, Jian
Wang, Gang Greg
EXPERIMENTAL HEMATOLOGY, 2015, 43 (08) : 698 - 712
[6] EZH2 as an Epigenetic Regulator of Cardiovascular Development and Diseases
Yuan, Jia-Li
Yin, Cheng-Ye
Li, Ying-Ze
Song, Shuai
Fang, Guo-Jian
Wang, Qun-Shan
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (02) : 192 - 201
[7] Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2
Dudakovic, Amel
Camilleri, Emily T.
Xu, Fuhua
Riester, Scott M.
McGee-Lawrence, Meghan E.
Bradley, Elizabeth W.
Paradise, Christopher R.
Lewallen, Eric A.
Thaler, Roman
Deyle, David R.
Larson, A. Noelle
Lewallen, David G.
Dietz, Allan B.
Stein, Gary S.
Montecino, Martin A.
Westendorf, Jennifer J.
van Wijnen, Andre J.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (46) : 27604 - 27617
[8] Epigenetic modification in gliomas: role of the histone methyltransferase EZH2
Bian, Er-Bao
Li, Jia
He, Xiao-Jun
Zong, Gang
Jiang, Tao
Li, Jun
Zhao, Bing
EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (10) : 1197 - 1206
[9] EZH2 Mutations: Mutating the Epigenetic Machinery in Myeloid Malignancies
Abdel-Wahab, Omar
Levine, Ross L.
CANCER CELL, 2010, 18 (02) : 105 - 107
[10] Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation
Galvan, M. Lizeth
Paradise, Christopher R.
Kubrova, Eva
Jerez, Sofia
Khani, Farzaneh
Thaler, Roman
Dudakovic, Amel
van Wijnen, Andre J.
BONE, 2021, 150

← 1 2 3 4 5 →